Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia
文献类型：期刊论文
| 作者 | Zhou, Guangbiao ; Hu, Zheng ; Pan, Xiaofen ; Liu, Jinglei ; Ma, Liyuan ; Liu, Xiaoli ; Meng, Fanyi ; Li, Juan ; Chen, Zhu ; Chen, Saijuan |
| 刊名 | BLOOD
 |
| 出版日期 | 2007 |
| 卷号 | 110期号:11页码:214B-214B |
| ISSN号 | 0006-4971 |
| 学科主题 | Hematology |
| 语种 | 英语 |
| 公开日期 | 2016-12-16 |
| 源URL | [http://ir.gibh.ac.cn/handle/344009/629]  |
| 专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
| 推荐引用方式 GB/T 7714 | Zhou, Guangbiao,Hu, Zheng,Pan, Xiaofen,et al. Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia[J]. BLOOD,2007,110(11):214B-214B. |
| APA | Zhou, Guangbiao.,Hu, Zheng.,Pan, Xiaofen.,Liu, Jinglei.,Ma, Liyuan.,...&Chen, Saijuan.(2007).Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia.BLOOD,110(11),214B-214B. |
| MLA | Zhou, Guangbiao,et al."Proteasome inhibitor/imatinib combinations exert potentiated antileukemia efficacy but not cardiotoxicity in chronic myeloid leukemia".BLOOD 110.11(2007):214B-214B. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。